Jeremy Y. Yap

Abstract 3425: The discovery and characterization of CFT1946: A potent, selective, and orally bioavailable degrader of mutant BRAF for the treatment of BRAF-driven cancers

M. Sowa, L. Poling, Yanke Liang, 2023, Cancer Research.